GlassScriptPhysician profile
Michael Joshua Haber
NPI 1477667053
$526.91
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $14.58 · 2022: $176.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $76.65 | 2019 | |
| Amgen INC. | $65.61 | 2019 | |
| Collegium Pharmaceutical, INC. | $54.41 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.85 | 2022 | |
| Nevro Corp. | $49.92 | 2019 | |
| Grt US Holding, INC. | $45.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $42.67 | 2019 | |
| Lilly USA, LLC | $41.28 | 2019 | |
| Impel Pharmaceuticals INC. | $22.53 | 2022 | |
| Assertio Therapeutics, INC. | $19.69 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.31 | 2019 | |
| Dynavax Technologies Corporation | $14.58 | 2020 | |
| Allergan, INC. | $12.25 | 2019 | |
| Si-Bone, INC. | $11.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Haber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.